You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Darzalex Faspro

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

Not yet recruiting
  • Peripheral Neuropathy
  • Monoclonal Gammopathy of Undetermined Significance
  • Daratumumab and hyaluronidase-fihj
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Sep 14, 2023

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,

Not yet recruiting
  • Non-small Cell Lung Cancer With STK11/LKB1 Mutation
  • Daratumumab and Hyaluronidase-fihj
  • +2 more
  • New York, New York
    NYU Langone Health
Mar 29, 2023

Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life

Not yet recruiting
  • Plasma Cell Myeloma
  • Daratumumab and Hyaluronidase-fihj
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022

Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

Enrolling by invitation
  • Antibody-mediated Rejection
  • Cardiac Transplant
  • Daratumumab and hyaluronidase-fihj
  • Rochester, Minnesota
    Mayo Clinic Rochester
Apr 11, 2022

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 7, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Multiple Myeloma Trial in Worldwide (GEN3014 (HexaBody®-CD38))

Recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +19 more
Dec 12, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
Mar 18, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 30, 2021

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Healthy Trial in Saint Petersburg (BCD-264, Darzalex)

Active, not recruiting
  • Healthy
  • Saint Petersburg, Russian Federation
  • +2 more
Jul 25, 2023

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma Trial in United States (drug,

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Anchorage, Alaska
  • +459 more
Dec 7, 2022

Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

Recruiting
  • Highly Sensitized Prospective Kidney Transplant Recipients
  • daratumumab
  • +2 more
  • San Francisco, California
    University of California at San Francisco Medical Center
Jan 27, 2022

Kyprolis® in Combination With Revlimid® and Dexamethasone or

Recruiting
  • Multiple Myeloma in Relapse
  • Frankfurt, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Malignant Tumors of Male Genital Organs, Prostate Cancer Trial (Daratumumab)

Withdrawn
  • Malignant Neoplasms of Male Genital Organs
  • Prostate Cancer
  • (no location specified)
Apr 20, 2017